RALEIGH -- Raleigh-Durham International Airport announced Tuesday that Midwest Airlines will begin service to Milwaukee on April 1.
Midwest will offer the service twice daily on the 76-seat Embraer-170 aircraft.
Midwest Airlines, operating as Midwest Connect, offered service between RDU and Milwaukee from 2007 until 2008 and as Midwest Express between 1998 and 2001.
"RDU is happy to welcome Midwest Airlines back to the Research Triangle Region," said Teresa Damiano, director of Marketing for the Airport Authority. "Each year, more than 50,000 passengers travel between RDU and Milwaukee."
Duke CE No. 1 for education
DURHAM -- Duke Corporate Education has been ranked the world's top provider of custom executive education in BusinessWeek magazine's Nov. 16 issue.
This is Duke CE's fourth consecutive top rating in the magazine's biennial survey of corporate learning professionals across industries.
"It is a humbling honor to receive this recognition since it is based on survey feedback from clients," said CEO Kim Taylor-Thompson. "The economic crisis presented us with the opportunity to rethink approaches and ways that we can enable learning to be even more relevant and accessible, and this is an amazing example of what occurs when you combine focused teamwork with deep collaboration. We will continue to work hard at being a good partner."
Duke CE has also been No. 1 for seven consecutive years in the Financial Times.
Duke, Jubilant join together
DURHAM AND NEW DELHI, INDIA -- Duke University and Jubilant Organosys Limited of India have signed a Letter of Intent to develop a partnership to expedite translation of discoveries by Duke scientists into clinical therapies.
The proposed partnership, signed by Jubilant's subsidiaries, Jubilant Biosys Limited and Jubilant First Trust Healthcare Limited, will move into a definitive agreement by the first quarter of 2010.
Duke and Jubilant will commit to five years together, with the objective of developing a portfolio of four to five technologies.
Glaxo donating H1N1 vaccines
LONDON -- GlaxoSmithKline announced Tuesday that it has signed an agreement with the World Health Organization to donate 50 million doses of its H1N1 flu vaccine for distribution to developing countries most in need.
GSK is working with WHO and health authorities to prepare for initial shipments by the end of November.
GSK is also supplying its vaccine to developing countries under a tiered pricing policy that would allow the world's poorest countries to receive preferential prices, based on volume orders. GSK has allocated 20 percent of overall production of its Canadian manufacturing site to developing countries.
-- From staff reports
